- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00332514
Post-Discharge Follow-Up Phone Call by a Pharmacist and Impact on Patient Care
The purpose is to analyze whether a follow-up telephone call by a pharmacist after patient discharge from the hospital can improve patient outcomes.
Patients will be interviewed via telephone within 72 hours of being discharged home from the hospital. Patients will be questioned on three main topics. They are:
- Medical care
- Medications
- Follow-up appointments
The purpose is to find out if people understand discharge medications, have obtained those medications, are having any problems with their medications and have scheduled necessary follow-up appointments. It will be determined if a telephone call by a pharmacist will prevent patients from needing to go to the Emergency Room or being admitted back to the hospital.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is a time between hospital discharge and patient follow-up that has been deemed by many healthcare workers as a "black hole " (1). It is a time during which continuity of care is of utmost importance, yet there is no effective uniform system in place to ensure this vital continuity. During the post-discharge period (time from when the patient leaves the hospital to the time of first follow-up appointment), new medical problems can arise and old ones can be exacerbated. Additionally, patients can encounter innumerable barriers to healthcare, including difficulty obtaining medications and securing appointments with physicians or specialists. Also, patients may not have received proper counseling on new discharge medications, including proper use and potential side effects. Despite this important aspect of patient care, only a paucity of literature on the topic exists. Of the literature that does exist, it suggests that patient education concerning discharge planning and the post-discharge period is an aspect of care that is in great need of improvement and an excellent opportunity for intervention by a pharmacist.
This led to our research hypothesis, can a follow-up phone call from a pharmacist improve patient outcomes?
The primary endpoint of this study is a reduction in the number of hospital readmissions (any cause) during the 30-day post-discharge period. Thirty-day readmission rates will be compared to see if there is a difference between the intervention group (follow-up phone call) and control group (no phone call). The secondary outcomes include the number of patients in the study group for whom medication errors, complications or misuse could be identified.
References: (1). Kathuria, et al. Post-discharge follow-up: hospitalists dial into the "black hole". Hospitalist and Inpatient Management Report, June 2003
Study Type
Enrollment
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Boston Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- admission to Internal Medicine Service on the Menino Pavilion, either Firm A or B at Boston Medical Center located in Boston, MA
- age greater than or equal to 18 years
- discharge to home from the inpatient General Medical Service
- English-speaking or lives with English-speaking person
- access to a working phone
Exclusion Criteria:
- admission to any other service at Boston Medical Center located in Boston, MA besides Internal Medicine Firms A or B
- age less than 18 years
- discharge to site other than home
- non-English-speaking or does not live with an English-speaking person
- no access to a working phone
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Patients offered follow-up phone call
Patients offered follow-up telephone call
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
The primary endpoint of this study is a reduction in the number of hospital readmissions (any cause) during the 30-day post-discharge period.
|
Secondary Outcome Measures
Outcome Measure |
---|
The secondary outcomes include the number of patients in the study group for whom medication errors, complications or misuse could be identified.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gail M Burniske, PharmD, BCPS, Boston Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- H-23071
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Readmission, Hospital
-
Luzerner KantonsspitalUniversity of LucerneCompletedHospital ReadmissionSwitzerland
-
Weill Medical College of Cornell UniversityMaimonides Medical Center; New York State Department of HealthCompletedHospital ReadmissionUnited States
-
Brigham and Women's HospitalHarvard Risk Management FoundationCompletedHospital ReadmissionUnited States
-
Amsterdam UMC, location VUmcUnknownHospital ReadmissionDenmark, Netherlands, United Kingdom
-
Zealand University HospitalRegion Zealand; Roskilde Municipality; Køge Municipality; Stevns Municipality; Solrød... and other collaboratorsCompletedDischarge Planning | Readmission, HospitalDenmark
-
Radboud University Medical CenterNot yet recruitingReadmission | Inpatient Endoscopy Delay | Prolonged Hospital StayNetherlands
-
Universidad Autonoma de Nuevo LeonCompletedHospital Readmission | Newborn Morbidity | Newborn | Newborn Complication
-
Unity Health TorontoCanadian Institutes of Health Research (CIHR)RecruitingHospital Readmission | Primary Care | Case Management | Homeless PersonsCanada
-
Zealand University HospitalNykøbing Falster County Hospital; Region Zealand; Lolland Municipality; Guldborgsund... and other collaboratorsCompletedReadmission | Discharge Planning | Hospital | Frail Elderly PatientsDenmark
-
Wake Forest University Health SciencesCompletedHospital ReadmissionUnited States
Clinical Trials on telephone call by a pharmacist
-
Institut für Pneumologie Hagen Ambrock eVCompleted
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Swansea UniversityAbertawe Bro Morgannwg University Health BoardRecruitingPelvic Floor DysfunctionsUnited Kingdom
-
University of WaterlooCompletedMedication Therapy Management | Home Care | PharmacistsCanada
-
University of CopenhagenRecruitingWisdom TeethDenmark
-
Maimonides Medical CenterCompletedParkinson Disease | Alzheimer Disease | DysphagiaUnited States
-
Groupe Hospitalier Diaconesses Croix Saint-SimonRecruitingHip Arthropathy Associated With Other ConditionsFrance
-
University Hospital, AngersCompletedPseudoxanthoma Elasticum | EmploymentFrance
-
Universitätsklinikum Hamburg-EppendorfCharite University, Berlin, Germany; University Hospital Muenster; University... and other collaboratorsRecruiting
-
Xuanwu Hospital, BeijingRecruiting